Award
Delivery Order #SPE2DR26FX1EP
AmerisourceBergen Delivery Order for Meloxicam under Healthcare IDV Contract
Buyer
Defense Logistics Agency
Award Amount
$37.76
Ceiling
$37.76
Awarded
March 11, 2026
Period of Performance
Mar 11, 2026 – Mar 12, 2026
Identifier
SPE2DR26FX1EP
NAICS
325411
This award is a definitive delivery order contract issued under a pre-existing indefinite delivery vehicle (IDV) held by AmerisourceBergen Drug Corp, a leading pharmaceutical distributor specializing in healthcare logistics and supply chain management. The order procures Meloxicam 15mg (1000 tablets), a nonsteroidal anti-inflammatory drug vital for patient care and treatment. This delivery order supports ongoing healthcare service provision facilitated by the parent IDV contract, which plays a significant role in ensuring timely availability of essential pharmaceuticals to government healthcare facilities. The contract scope includes the supply and distribution of this specific pharmaceutical product within a short term, emphasizing prompt fulfillment. Awarded as a directed order under the sole-source IDV framework, this contract leverages AmerisourceBergen’s exclusive capabilities to meet government health service demands efficiently. The contract's performance is scheduled for a brief period in early 2026, marking a focused procurement effort that contributes to sustained medical supply chain operations.
Description
4571109652!MELOXICAM 15MG 1000S